Dotson Jerrold Duane

VP, CFO AND SECRETARYVistaGen Therapeutics, Inc. (VTGN) · full profile →Form 4 · filed Jul 2, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
4 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 30, 2021Option exercise(M)10K$0.40$4K103K
Jun 30, 2021Option exercise(M)79K$1.00$79K93K
Jun 30, 2021Option exercise(M)1K$1.50$2K14K
Jun 30, 2021Grant(A)3K$1.95$6K13K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 30, 2021Option exercise(M)1K$00
Jun 30, 2021Disposed to issuer(D)37K$0113K
Jun 30, 2021Option exercise(M)10K$0140K
Jun 30, 2021Option exercise(M)79K$034K

Transaction Codes

M
Option exercise / conversion
A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-21-003391) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.